Sairiyo Therapeutics Inc.
PharmaTher owns 49% of Sairiyo Therapeutics. We plan to crystallize the value through various avenues, which may include the sale of all or part of our interest, a spin-out, or another public company transaction.
© COPYRIGHT 2026. PharmaTher Holdings Ltd. ALL RIGHTS RESERVED.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."